novo nordisk glp 1 Ozempic is first GLP-1 drug FDA-approved for kidney disease A New Era of Weight

We often hear about the gastrointestinal side effects of these weight loss medications

The indirect effects, mediated through reductions in HbA1c and body weight, appeared to explain 45.9% [95% CI 20.771.0%] of the decrease in UACR associated with tirzepatide relative to the pooled comparator and driven primarily by improved glycemic control, with no statistically significant role for weight reduction

1) (Marso et al 2016

GLP-1 receptor agonist alternatives The closest alternatives to tirzepatide are other medications that target the same GLP-1 receptor pathway

the randomized trial investigated exenatide against a placebo control, 810 while the cohort and casecontrol studies compared either semaglutide, liraglutide, or tirzepatide against usual care management

How Phentermine and GLP-1 Medications Work Differently Phentermine is a Schedule IV controlled substance that stimulates the release of norepinephrine in the brain, increasing alertness, energy, and appetite suppression